The invention encompasses compounds of Formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. ##STR00001##
Web www.patentalert.com
< Method for selective inactivation of viral replication
> Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT